A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety ' Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Trial Profile

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety ' Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Terbinafine (Primary)
  • Indications Onychomycosis
  • Focus Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical
  • Most Recent Events

    • 02 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top